Our Corporate News
Atessia Conducts Regulatory Due Diligence for BC Partners in the Acquisition of Biogaran
In late July 2025, Atessia, a consulting firm specialized in regulatory and pharmaceutical affairs, supported BC Partners in the acquisition of Biogaran, a leading player
Atessia takes a strategic leap with the integration of AnticipSanté
This merger enriches our service offering and affirms our commitment to supporting healthcare players in meeting the regulatory and operational challenges of today and tomorrow.
ATESSIA, Your Guide to Efficient Regulatory Affairs in the Pharma Industry
In the intricate and highly regulated world of pharmaceuticals and healthcare, ATESSIA stands out as a consulting firm dedicated to guiding companies through the complexities
ATESSIA Named Among the “5 Best Pharma Consulting Companies to Watch in 2024”
We are proud to be featured in The Silicon Review, a recognition that highlights our unwavering commitment to excellence in regulatory affairs. In the pharmaceutical
Forbes – ATESSIA, Life Science Advisors : The Regulatory and Pharmaceutical Affairs Consulting Firm Dedicated to the Healthcare Industry
Leveraging its expertise, ATESSIA supports a wide range of health products, with a particular focus on pharmaceuticals and medical devices. Through a tailored and rigorous
ATESSIA Life Science Advisors, a Catalyst for Regulatory Innovation: Collaborating with UBAQ, ATESSIA Sets a New Standard to Facilitate the Management of Regulatory Challenges in the Health Sector
An alliance capable of moving mountains. ATESSIA and UBAQ jointly pave the way for health sector players. The health sector, constantly evolving and in the